Keefe, Bruyette & Woods Reinstates Outperform on Globe Life, Announces $168 Price Target

Benzinga Newsdesk www.benzinga.com Positive 65.5%

Neg 0% Neu 0% Pos 65.5%

Keefe, Bruyette & Woods analyst Ryan Krueger reinstates Globe Life (NYSE:GL) with a Outperform and announces $168 price target.